Advertisement

Pre-implantation viability of cryopreserved valves prepared by the Green Lane Technique

  • L. C. Armiger
  • B. G. Barratt-Boyes

Abstract

Objective: The importance of a viable donor cell population to the durability and clinical performance of the allografted heart valve is still disputed. The aim of our investigations has been to establish the pre-implantation viability status of the cryopreserved valves currently prepared for use as allografts at Green Lane Hospital and to correlate this with the cellular status of explanted cryopreserved grafts recovered at re-operation.

Methods: Viability was assessed primarily by an autoradiographic assay for the incorporation of glucosamine into proteoglycan matrix and results were compared with cell culture assays and cell ultrastructure. Twenty-six valves were obtained at autopsy and assayed sequentially 1) at collection; 2) after disinfection in antibiotic solution; 3) after thawing following cryopreservation and storage. A second group of 45 similarly disinfected and cryopreserved banked valves considered unsuitable for clinical use was assayed after thawing.

Results: Most of the banked valves showed only sparse radiolabelling confined to the hinge area of the leaflet. By electron microscopy, the unlabelled cells showed severe damage to plasma membranes and cytoplasm. In the autopsy series, valves obtained 24–48 h after donor death were non-viable at collection. Those obtained within 24 h of donor death showed variable extents of radiolabelling, but this declined markedly after 24 h of exposure to antibiotics and progressively still further after 48 h of antibiotic treatment and cryopreservation. Whereas 85% of all valves collected were viable initially, only 15–20% remained viable following disinfection and storage.

Conclusions: The majority, though not all, of the cryopreserved valves prepared at Green Lane Hospital are currently non-viable when implanted. The first 25 explanted cryopreserved valves examined histologically all show some focal fibroblastic growth which may presumably be either donor or recipient in origin. The disinfection and cryopreservation procedures in use at present have additive adverse effects on the cell viability of hypoxically-injured cadaver-derived valves.

Keywords

Aortic Valve Donor Death Aortic Valve Leaflet Cell Culture Assay Proteoglycan Matrix 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Angell WW, de Lanerolle P, Shumway NE (1973) Valve replacement: present status of homograft valves. Progr Cardiovasc Dis 15: 589–622CrossRefGoogle Scholar
  2. 2.
    Armiger LC, Gavin JB, Barratt-Boyes BG (1983) Histological assessment of orthotropic aortic valve leaflet allografts: its role in selecting graft pre-treatment. Pathology 15: 67–73PubMedCrossRefGoogle Scholar
  3. 3.
    Armiger LC, Thomson RW, Strickett MG, Barratt-Boyes BG (1985) Morphology of heart valves preserved by liquid nitrogen freezing. Thorax 40: 778–786PubMedCrossRefGoogle Scholar
  4. 4.
    Armiger LC (1995) Viability studies of human valves prepared for use as allografts. Ann Thorac Surg 60: S118–121PubMedCrossRefGoogle Scholar
  5. 5.
    Barratt-Boyes BG (1971) Long-term follow-up of aortic valvar grafts. Br Heart J 33(Suppl): 60–65PubMedCrossRefGoogle Scholar
  6. 6.
    Fischlein T, Schutz A, Haushofer M, Frey R, Uhlig A, Detter C, Reichart B (1995) Immunological reaction and viability of cryopreserved homografts. Ann Thorac Surg 60: S122–126PubMedCrossRefGoogle Scholar
  7. 7.
    Hu J-F, Gilmer L, Hopkins R, Wolfinbarger L (1989) Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovasc Res 23: 960–964PubMedCrossRefGoogle Scholar
  8. 8.
    Merrilees MJ, Scott L (1982) Organ culture of rat carotid artery: maintenance of morphological characteristics and of pattern of matrix synthesis. In Vitro 18: 900-910Google Scholar
  9. 9.
    O’Brien MF, Stafford EG, Gardner MAH, Pohlner P, McGiffin DC, Johnston N, Tesar P, Brosnan A, Duffy P (1988) Cryopreserved viable allograft aortic valves. In: Yankah AC, Hetzer R, Miller DC, Ross DN, Somerville J, Yacoub MH (eds) Cardiac valve allografts 1962–1987. Steinkopff, Darmstadt; Springer, New York, pp 311–321Google Scholar
  10. 10.
    O’Brien MF, Stafford EG, Gardner MAH, Pohlner PG, Tesar PJ, Cochrane AD, Mau TK, Gall KL, Smith SE (1995) Allograft aortic valve replacement: Long-term follow-up. Ann Thorac Surg 60: S565–570Google Scholar
  11. 11.
    Strickett MG, Barratt-Boyes BG, MacCulloch D (1983) Disinfection of human heart valve allografts with antibiotics in low concentrations. Pathology 15: 457–462PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • L. C. Armiger
    • 1
    • 2
  • B. G. Barratt-Boyes
    • 1
  1. 1.Department of PathologyUniversity of Auckland School of Medicine, and Green Lane HospitalAucklandNew Zealand
  2. 2.Department of Pathology, School of MedicineUniversity of AucklandAuckland 1New Zealand

Personalised recommendations